Related Experiment Video
Updated: Jun 17, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Job matters: differences in risk assessment of percutaneous aortic valve replacement between cardiologists and
1Departments of Economics and Internal Medicine I, Friedrich-Schiller-University, Jena, Germany.
Insights
Cardiologists and cardiac surgeons have differing views on percutaneous aortic valve replacement (PAVR). While both groups acknowledge risks and benefits, cardiologists perceive PAVR advantages more optimistically than surgeons.
Area of Science:
- Cardiology
- Cardiac Surgery
- Interventional Cardiology
Background:
- Percutaneous aortic valve replacement (PAVR) offers an alternative to traditional operative valve replacement for aortic stenosis.
- The efficacy and safety of various PAVR devices are under continuous evaluation.
- Collaboration between cardiologists and cardiac surgeons is essential for assessing PAVR.
Purpose of the Study:
- To compare how cardiologists and cardiac surgeons assess the risks and benefits of PAVR.
- To identify significant differences in the judgments between these two medical groups.
Main Methods:
- An online questionnaire was administered to 51 cardiologists and 54 cardiac surgeons in Germany.
- The questionnaire included 11 questions focusing on the risks and benefits associated with PAVR.
- Statistical analysis, including regression analysis, was used to compare responses and identify influencing factors.
Main Results:
- Significant differences were observed in the responses of cardiologists and cardiac surgeons regarding PAVR.
- Cardiologists rated risks such as hemodynamic compromise, paravalvular leakage, and embolic events lower than cardiac surgeons.
- Cardiologists reported a significantly higher perceived advantage of PAVR, independent of personal experience.
Conclusions:
- Cardiologists and cardiac surgeons concur on the potential risks and benefits of PAVR, but with differing degrees of emphasis.
- Cardiologists exhibit a more optimistic outlook towards PAVR, leaning towards an interventional approach.
- Enhanced, evidence-based information may be crucial in mitigating group-specific biases regarding PAVR.
Background:
Percutaneous aortic valve replacement (PAVR) for aortic stenosis is an attractive alternative to operative valve replacement. Several devices are evaluated, but their efficacy and safety are critically discussed. An interdisciplinary approach with collaboration of cardiac surgeons and cardiologists is widely requested. We analyzed how cardiologists and cardiac surgeons assess the possibilities and risks of PAVR and whether there are substantial differences between the judgments of these 2 groups.
Methods And Results:
Fifty-one cardiologists and 54 cardiac surgeons from German hospitals completed an online questionnaire consisting of 11 questions dealing with typical risks and benefits of PAVR. Answers to all questions differed significantly between surgeons and cardiologists. Risks as impaired hemodynamic outcome, paravalvular leakage, or embolic events were deemed higher for PAVR than for an operation from both groups, but cardiologists rated those risks significantly lower than cardiac surgeons (P<0.01 for all questions). A regression analysis with a latent variable approach for possible advantages of PAVR (like minor operative trauma, faster recovery, less pain) showed that the fact of being a cardiologist has a significant impact on the rating of PAVR advantages (r=0.719, P<0.01), whereas personal experience showed no significant effect.
Conclusions:
Cardiologists and cardiac surgeons agree on possible risks and advantages of PAVR, but the extent differs significantly between the 2 groups. Cardiologists have a far more optimistic view of PAVR and are likely to favor an interventional approach. More and better evidence based information may help to overcome group related prejudices.
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Cardiac Catheterization I: Pre-Procedure Overview
